Results 241 to 250 of about 4,877,549 (387)
Human Cyclophilins—An Emerging Class of Drug Targets
ABSTRACT Cyclophilins are a family of enzymes with peptidyl‐prolyl isomerase activity found in all cells of all organisms. To date, 17 cyclophilin isoforms have been identified in the human body, participating in diverse biological processes. Consequently, cyclophilins have emerged as promising targets for drug development to address a wide array of ...
Katarina Jurkova +3 more
wiley +1 more source
Evaluating Radiotheranostic Targets for Endometrial Cancer. [PDF]
Sebastiano J +7 more
europepmc +1 more source
Diffusion-weighted imaging in the assessment of tumour grade in endometrial cancer
Nishat Bharwani +6 more
openalex +2 more sources
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu +13 more
wiley +1 more source
Serum expression levels of HOTAIR and miR-646 in endometrial cancer. [PDF]
Harismunandar R +6 more
europepmc +1 more source
Differential Proteomics of Large Extracellular Vesicles in Ovarian Cancer
ABSTRACT Diverse extracellular vesicles (EVs) are present in all body fluids; however, knowledge of large EVs (lEVs) remains limited. Molecular EV profiles vary depending on EV size and the physiological circulatory system, even within the same patient. In this study, we aimed to characterize the proteomic profile of IEVs in ovarian cancer patients and
Kazuhiro Suzuki +6 more
wiley +1 more source
L1CAM Promotes Human Endometrial Cancer Via NF-κB Activation. [PDF]
Kurosu H +16 more
europepmc +1 more source
Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next? [PDF]
Cripe, James C +8 more
core +1 more source

